NASDAQ:ORTX
Delisted

Orchard Therapeutics Stock Signals

etoro logo Buy ORTX
*Your capital is at risk
$16.70
+0 (+0%)
At Close: Mar 15, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Orchard Therapeutics plc

General

Signal Type Signal Value Data
Score 0.000 121 days ( -139.60 %
Last Price $16.70 0 %
Performance History
7 Days
$16.70 $16.70
0%
30 Days
$16.70 $16.70
0%
12 Mos
$4.66 $16.70
258.37%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 39.19
Signal Type Signal Value Importance Data
High / Low N/A Very Low $16.70 - $16.70
Trend - 3 mos 2.17 % High Width: 1.23 %
Pred. range - 3 mos $17.02 - $17.23 Low 1.94 % - 3.19 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Mar 14, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Jan 31, 2024 - 32 days
Short MA 3 mos Buy Low Jan 09, 2024 - 47 days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 60.24
Signal Type Signal Value Importance Data
Trend - 12 mos 322.32 % Very High Width: 63.80 %
Pred. range - 12 mos $57.06 - $93.47 High 241.68 % - 459.69 %
Short MA 12 mos Sell Very High Jan 10, 2024 - 46 days
Long MA 12 mos Buy Very High Sep 14, 2023 - 127 days
Short/Long MA 12 mos Buy Very High Sep 19, 2023 - 124 days
Pivot Long Sell Low Mar 14, 2024 - 2 days
RSI Long Pivot Signal Sell Low Feb 09, 2024 - 25 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ORCHARD THERAPEUTICS PLC
Orchard Therapeutics
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE